Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2019-11-22

FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC — Supplemental Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

FDA supplements the labeling for the atovaquone and proguanil hydrochloride pediatric product, expanding pediatric dosing and indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atovaquone and Proguanil Hydrochloride Pediatric (atovaquone and proguanil hydrochloride)

Snippet

SUPPL AP for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE PEDIATRIC)